Rockwell Medical (RMTI) Tops Q1 EPS by 12c
Tweet
Share
E-mailGet Alerts RMTI Hot Sheet
Price: $8.04 +1.01%
Revenue Growth %: +14.9%
Financial Fact:
Research and Product Development: 1.26M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +14.9%
Financial Fact:
Research and Product Development: 1.26M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Rockwell Medical (NASDAQ: RMTI) reported Q1 EPS of ($0.10), $0.12 better than the analyst estimate of ($0.22). Revenue for the quarter came in at $19.7 million versus the consensus estimate of $19.12 million.
For earnings history and earnings-related data on Rockwell Medical (RMTI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Oracle (ORCL) Tops Q1 EPS by 19c, Beats on Revenue; Beats on Cloud Revenue, Offers Q3 EPS Guidance
- Copart to buy ACV for $1.9 billion in cash deal
- Adobe beats Q3 targets, but soft Q4 sales guidance triggers dip
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
